Tagged: series-b
30 results
mx51
mx51 is a Sydney-based fintech that provides a bank-grade, cloud-native Payment-as-a-Service platform. Spun out of Assembly Payments in 2020, it gives banks, acquirers and payment providers white-label, multi-channel payment infrastructure - in-store terminal software, merchant and support dashboards, analytics and 150+ point-of-sale integrations - so they can serve merchants without building the technology themselves. Its customers include Commonwealth Bank and Westpac, and the platform has processed billions of dollars in transactions across the Asia-Pacific region.
Allen Control Systems
Allen Control Systems (ACS) is an Austin-based defense technology company building Bullfrog, an AI-powered autonomous robotic weapon station designed to detect, track and shoot down hostile drones. Founded in 2022 by three engineer-entrepreneurs, ACS uses passive machine vision and custom fire-control software to turn standard machine guns into precision counter-drone turrets, aiming to cut the cost-per-kill of a drone from expensive missiles down to a few dollars of ammunition. The company raised a $200M Series B in 2026 at a $2.2B valuation to scale manufacturing for the U.S. military and allied forces.
CREATE Medicines
CREATE Medicines is a Cambridge, Massachusetts clinical-stage biotech building in vivo immune programming - therapies that use an mRNA-lipid nanoparticle platform to turn a patient's own T cells, NK cells, and myeloid cells into chimeric antigen receptor (CAR) cells directly inside the body, rather than extracting and re-engineering them in a lab. Formerly Myeloid Therapeutics, the company rebranded in October 2025 as its pipeline expanded beyond myeloid cells and cancer into autoimmune disease and fibrosis. Its repeat-dosable, off-the-shelf approach aims to make CAR therapy cheaper and more scalable than conventional cell therapy, and the company says it has dosed more than 50 patients - among the largest clinical datasets for in vivo CAR to date.
Illimis Therapeutics
Illimis Therapeutics is a Seoul-based biotechnology company developing protein-based medicines for central nervous system and immune diseases. Its proprietary GAIA (Gas6-mediated Anti-Inflammatory Adaptor) platform builds bispecific fusion proteins that engage the body's TAM receptors to clear misfolded proteins such as amyloid-beta through phagocytosis without triggering the inflammation and ARIA side effects associated with existing antibody drugs. Founded in 2021, the company raised a $42 million Series B in July 2025 and is advancing a lead Alzheimer's candidate, ILM01, toward an IND by the end of 2027.
Nuvig Therapeutics
Nuvig Therapeutics is a clinical-stage biotech in the San Francisco Bay Area developing next-generation immune modulators for chronic autoimmune and inflammatory diseases. Founded in 2022 on research from The Rockefeller University, its lead candidate NVG-2089 is a first-in-class recombinant Fc fragment that engages type II Fc receptors to recapitulate the anti-inflammatory benefits of IVIg without immunosuppression or the supply constraints of plasma-derived products. The company raised a $161M Series B in December 2024 to push NVG-2089 into Phase 2 for CIDP and other indications.
Mathias Fort
Mathias Korder Fort is co-founder and CEO of Baselane, a New York-based fintech that gives independent landlords a single place to bank, collect rent, and keep books. In October 2025 the company closed a $20M Series B led by Thomvest Ventures, and simultaneously disclosed a previously-unannounced $14.4M Series A led by Matrix Partners, bringing total funding to roughly $44M. Before Baselane he spent seven years as a Principal in Boston Consulting Group's financial services practice, and started his career as an analyst at Morgan Stanley. He holds an MBA from INSEAD and a BA in economics from Trinity College.
Michael Hershfield
Michael Hershfield is the founder and CEO of Accrue, a New York fintech that lets retailers embed FDIC-insured, brand-customized savings wallets inside their shopping experience. He built the company around a simple flip of buy-now-pay-later: save first, then spend. Before Accrue, he was SVP of Sales at WeWork and COO at Nucleus, with earlier operating stints across Kitchensurfing, Sailthru, Howcast, and his own ticketing startup LiveStub.
Nick Macario
Nick Macario is co-founder and CEO of Verifiable, an Austin-based healthcare credentialing platform that replaces weeks of paperwork with API-driven verifications and, more recently, an autonomous AI agent called CredAgent. A multi-time founder (Branded.me, Remote.com, Dock.io), he raised a $27M Series B from Craft Ventures in 2023 and is backed by Sam and Jack Altman.
Sahir Jaggi
Sahir Jaggi is the founder and CEO of Forus, an AI-powered network (formerly known as Tandem) that automates the paperwork sitting between a doctor's prescription and a patient actually getting the drug. Forus emerged from stealth in May 2026 with $160M in funding at a $1B valuation from Thrive Capital, General Catalyst, and Accel. Before Forus, Jaggi spent six years as a product leader at Oscar Health after studying biomedical engineering and computer science at Columbia.
AltruBio Inc.
AltruBio is a clinical-stage San Francisco biotech developing first-in-class immune checkpoint enhancer antibodies for autoimmune and inflammatory diseases. Its lead program, ALTB-268, targets PSGL-1 to restore T-cell homeostasis, and is advancing through mid-stage trials in ulcerative colitis. The company rebranded from AbGenomics in 2020 under CEO Judy Chou and closed an oversubscribed $225M Series B in 2024.
Myra Vision
Myra Vision is a Campbell, California medical device company developing the Calibreye Titratable Glaucoma Therapy Surgical System - a next-generation aqueous shunt with adjustable outflow channels that let surgeons fine-tune intraocular pressure in glaucoma patients non-invasively in the clinic, long after the implant goes in.
Nitricity
Nitricity is a Fremont, California climate-tech company turning air, water, renewable electricity and discarded almond shells into organic nitrogen fertilizer. Its flagship product, Ash Tea, replaces fossil-fuel-derived fertilizers with a regionally produced, OMRI- and CDFA-certified alternative that cuts emissions by more than 90%. Founded in 2018 by three Stanford PhDs, the company closed a $50M Series B in September 2025 and is building its first commercial plant in Delhi, California.
Avelos Therapeutics
Avelos Therapeutics is a Seoul-based clinical-stage oncology biotech founded in 2021 that designs small-molecule drugs for 'undruggable' cancer targets using synthetic lethality, DNA damage response (DDR), and cell-cycle biology. Its lead program, AD1208, is a first-in-class oral MASTL kinase inhibitor now in a Phase 1/2a solid-tumor trial. Backed by KRW 30 billion (~$21.7M) across seed, Series A, and a 2024 Series B, the roughly nine-person team is building a biomarker-driven pipeline of four anti-cancer candidates aimed at a future KOSDAQ listing.
Gate Bioscience
Gate Bioscience is a Brisbane, California biotech building a brand-new class of medicines it calls Molecular Gates: oral small molecules that stop disease-causing proteins from ever leaving the cell. Instead of chasing proteins after they are secreted into the body, Gate's drugs bind Sec61, the single channel every one of the roughly 4,000 human secreted and membrane proteins must pass through, and selectively block a target protein so the cell degrades it. Founded in 2021 and emerged from stealth in 2023 with $60M, the company has raised about $135M total and is pushing its lead programs toward IND-enabling studies and Phase 1 trials.
Sovato
Sovato is a Santa Barbara health-tech company building the first comprehensive, system-agnostic platform for remote robotic surgery and procedures - what the industry calls telesurgery. Co-founded by surgical-robotics pioneer Yulun Wang and healthcare strategist Cynthia Perazzo, Sovato lets a skilled surgeon operate a robotic system from hundreds or thousands of miles away, aiming to extend top surgical care to patients regardless of where they live. The company has raised $41M across its rounds and helped enable the longest-distance telesurgery ever completed.
Anyplace
Anyplace is a San Francisco-based housing platform that rents fully furnished, work-ready apartments for stays of 30 days or longer. Built for remote workers, relocating professionals, and corporate teams, every unit ships with a dedicated workspace, fast Wi-Fi, and a no-lease, move-in-ready setup in cities like New York, LA, San Francisco, Miami, and Tokyo.
Bedrock Robotics
Bedrock Robotics is a San Francisco startup retrofitting existing heavy construction equipment - excavators, dozers, articulated trucks - with an AI kit that turns them into 24/7 autonomous machines. Founded in 2024 by former Waymo leaders, the company raised a $270M Series B in February 2026 at a $1.75B valuation to scale its 'Bedrock Operator' platform across active job sites in the US.
Carta Healthcare
Carta Healthcare is a San Francisco health-tech company that pairs AI with expert nurse abstractors to pull clean, registry-ready data out of messy electronic medical records. Its Atlas and Lighthouse products cut abstraction costs by more than half while hitting 98-99% inter-rater reliability, freeing clinicians and hospitals from the slow, expensive grind of manual chart review.
DuploCloud
DuploCloud is a San Jose-based DevOps automation platform that turns plain-English application requirements into production-ready, compliance-aware cloud infrastructure across AWS, Azure and GCP. Founded by ex-Microsoft Azure engineer Venkat Thiruvengadam, it aims to give Main Street IT the hyperscale automation patterns once locked inside Big Tech.
Equilibrium Energy
Equilibrium Energy is a San Francisco-based clean power company building PowerOS, an agentic AI platform purpose-built for the power industry. Its flagship product, EQ Mission Control, optimizes battery storage and renewables portfolios across US power markets, blending grid physics, market modeling, and AI copilots.
Exodigo
Exodigo is an AI-powered underground mapping company that fuses multiple geophysical sensors with machine learning to produce non-intrusive 3D maps of what lies beneath the surface, helping transit agencies, utilities and engineers de-risk multi-billion-dollar infrastructure projects.
Flex
Flex is an AI-native private banking platform for high-net-worth, middle-market business owners. It bundles credit, business and personal banking, payments, AP automation, expense management, and ERP-style tooling into a single super app aimed at owner-operators of $3M-$100M revenue companies.
Flux
Flux is a browser-based, AI-native hardware design platform that turns text prompts into manufacturable printed circuit boards. The San Francisco company calls its product an 'AI Hardware Engineer' and is rewriting how electronics get designed by combining an electronic CAD environment with an agentic copilot that researches parts, draws schematics, lays out boards, and prepares files for fabrication.
Heirloom Carbon
Heirloom Carbon Technologies is a San Francisco-based direct air capture company that uses limestone's natural CO2-absorbing properties to pull carbon dioxide permanently out of the atmosphere. Their process accelerates a geological phenomenon that normally takes thousands of years into a 3-day cycle: calcium oxide powder absorbs CO2 from ambient air, becomes limestone, gets heated in a renewable-energy-powered electric kiln to release the captured CO2, and repeats. The captured CO2 is then stored permanently underground or embedded in concrete. Founded in 2020, Heirloom opened America's first commercial DAC facility in Tracy, California in November 2023 and has raised over $354 million to expand capacity toward their goal of removing 1 billion tons of CO2 by 2035.
Hevo Data
Hevo Data is a San Francisco-based SaaS company that builds no-code, automated data pipeline infrastructure for modern data teams. Founded in 2017 by Manish Jethani and Sourabh Agarwal, the platform connects 150+ data sources to warehouses like Snowflake, BigQuery, and Redshift in real time - with zero maintenance overhead. Backed by Sequoia Capital India with $43M in total funding, Hevo serves 2,000+ data teams across 40+ countries, processing over 1 petabyte of data monthly. The company had $46.9M ARR in 2024 and is recognized as a G2 Leader in ETL and iPaaS categories.
House Rx
House Rx is a San Francisco-based healthcare technology company that partners with specialty clinics to enable medically integrated dispensing (MID) - a model where physicians, pharmacists, nurses, and care coordinators work together as one unified team. Founded in 2021 by Flatiron Health veterans Ogi Kavazovic and Tesh Khullar, the company builds AI-enabled pharmacy management software that keeps specialty medications dispensed at the point of care, cutting average time-to-therapy from 15.5 days to 3.5 days and achieving 95% medication adherence. With $100M raised across Seed, Series A, and Series B rounds, House Rx serves 80 clinic sites, 1,000+ providers, and nearly 61,000 patients, processing approximately $1.5 billion in specialty prescriptions annually.
Incode
Incode is an AI-powered identity verification platform that lets businesses confirm who is really on the other side of a screen — in under two seconds. Founded in San Francisco in 2015, the company has built a modular biometric platform used by banks, hotels, hospitals, and gaming companies across more than 190 countries. Its flagship product, Incode Omni, handles everything from document verification and facial recognition to AML screening and liveness detection, processing more than 100 million user verifications per year. Backed by General Atlantic, SoftBank, J.P. Morgan, and Capital One Ventures at a $1.25 billion valuation, Incode has been named a Gartner Magic Quadrant Leader for Identity Verification two consecutive years running.
InVideo
InVideo is an AI-powered video creation platform that turns plain text into polished, publish-ready videos. Founded in 2017 in Mumbai and now headquartered in Daly City, California, the company serves 50+ million users across 190+ countries. Its flagship product InVideo AI lets anyone - from solo creators to enterprise marketing teams - generate scripts, visuals, voiceovers, and complete videos by typing instructions in plain English. In 2025, InVideo became the only platform bundling access to both OpenAI's Sora 2 and Google's VEO 3.1 under a single subscription, cementing its position at the frontier of AI-driven video production.
Joy
Joy is an all-in-one wedding planning platform that helps couples build custom wedding websites, manage registries with zero fees, coordinate guests, and stream virtual events. Founded in 2016 by three former Microsoft and Adobe engineers, Joy has grown to serve hundreds of thousands of couples worldwide with a free-to-use model, 600+ website templates, and a universal registry that pulls from any online retailer. Backed by General Catalyst and Sound Ventures, Joy has raised over $108M and is expanding beyond weddings into all major life milestones.
Lyric
Lyric is a Sunnyvale-based AI platform built for the people who actually run supply chains. Its Lyric Studio harmonizes data, algorithms, configurable workflows, and accelerated compute so that planners, engineers, and data scientists can model, test, and deploy decision intelligence apps - from demand forecasting and inventory to network design and transportation. Fortune 500 customers use it to compress months-long modeling cycles into days.